TY - CHAP
T1 - Artificial Activation of Murine Oocytes Using Strontium to Derive Haploid and Diploid Parthenotes
AU - Crasta, Daphne Norma
AU - Adiga, Satish Kumar
AU - Kannan, Nagarajan
AU - Kalthur, Guruprasad
N1 - Funding Information:
The author DNC acknowledges DST-Inspire fellowship and Fulbright-Nehru Doctoral Research Fellowship to conduct doctoral studies in NK’s laboratory.
Publisher Copyright:
© 2022, Springer Science+Business Media, LLC, part of Springer Nature.
PY - 2022
Y1 - 2022
N2 - Parthenogenesis is a common reproductive strategy among lower animals that involves the development of an embryo from an oocyte, without any contribution from spermatozoon. This phenomenon does not occur naturally in placental mammals. However, the mammalian oocytes can be artificially activated in vitro using mechanical, electrical, and chemical stimuli which can develop up to the blastocyst stage. In this chapter, we describe the protocol for generating haploid and diploid parthenotes from mouse oocytes using strontium as the activating agent under in vitro conditions.
AB - Parthenogenesis is a common reproductive strategy among lower animals that involves the development of an embryo from an oocyte, without any contribution from spermatozoon. This phenomenon does not occur naturally in placental mammals. However, the mammalian oocytes can be artificially activated in vitro using mechanical, electrical, and chemical stimuli which can develop up to the blastocyst stage. In this chapter, we describe the protocol for generating haploid and diploid parthenotes from mouse oocytes using strontium as the activating agent under in vitro conditions.
UR - http://www.scopus.com/inward/record.url?scp=85129433530&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85129433530&partnerID=8YFLogxK
U2 - 10.1007/978-1-0716-1979-7_2
DO - 10.1007/978-1-0716-1979-7_2
M3 - Chapter
C2 - 35507152
AN - SCOPUS:85129433530
VL - 2429
T3 - Methods in Molecular Biology
SP - 15
EP - 26
BT - Methods in Molecular Biology
PB - Humana Press Inc.
ER -